NCT07014826View on ClinicalTrials.gov

A Trial of HRS-5965 Capsule in Primary IgA Nephropathy

PHASE3RecruitingINTERVENTIONAL

Enrollment

378

Participants

Timeline

Start Date

June 4, 2025

Primary Completion Date

October 31, 2027

Study Completion Date

December 31, 2028

Conditions

Primary IgA Nephropathy

Interventions

DRUG

HRS-5965

HRS-5965

DRUG

Placebo

Placebo

Trial Locations (1)

100034

RECRUITING

Peking University First Hospital, Beijing

All Listed Sponsors

lead

Chengdu Suncadia Medicine Co., Ltd.

INDUSTRY